World Journal of Oncology, ISSN 1920-4531 print, 1920-454X online, Open Access |
Article copyright, the authors; Journal compilation copyright, World J Oncol and Elmer Press Inc |
Journal website http://www.wjon.org |
Original Article
Volume 1, Number 1, February 2010, pages 35-41
Analysis of Survival Rates of Patients Diagnosed With Incipient Esophagic Cancer
Tables
Variable | Category | n | % |
---|---|---|---|
Gender | Male | 15 | 83.3 |
Female | 3 | 16.7 | |
Age | ≤ 49 years old | 4 | 22.2 |
≥ 50 years old | 14 | 77.8 | |
State of origin | Minas Gerais | 5 | 27.8 |
Mato Grosso do Sul | 1 | 5.6 | |
Sao Paulo | 12 | 66.7 | |
Schooling | Non | 5 | 27.8 |
Basic incomplete | 11 | 61.1 | |
Basic complete | 1 | 5.6 | |
High school | 1 | 5.6 | |
Tabagism | Never/ Former smoker | 9 | 60.0 |
Current smoker | 6 | 40.0 | |
Etilism | Never | 6 | 37.5 |
Ever | 10 | 62.5 | |
Body Mass Index (BMI) | ≤ 18.5 | 5 | 29.4 |
18.5 – 25.9 | 6 | 35.3 | |
≥ 26.0 | 6 | 35.3 | |
Comorbidity | Absent | 11 | 61.1 |
Present | 7 | 38.9 | |
Second primary tumor | Yes | 5 | 27.8 |
No | 13 | 72.2 | |
Histological type | Squamous cell carcinoma | 16 | 88.9 |
Adenocarcinoma | 2 | 11.1 | |
Stage (TNM) | 0 | 3 | 16.7 |
1 | 15 | 83.3 | |
Therapeutics | Radiotherapy | 4 | 22.2 |
Surgery and radiotherapy | 1 | 5.6 | |
Surgery and chemotherapy | 1 | 5.6 | |
Radiotherapy and chemotherapy | 1 | 5.6 | |
Transthoracic esophagectomy | 4 | 22.2 | |
Transhiatal esophagectomy | 6 | 33.3 | |
Esophageal gastroplasty | 1 | 5.6 | |
Total | 18 | 100 |
Variable | Category | n | Free disease rates probabilities (%) | p (Log-Rank) | |
---|---|---|---|---|---|
12 months | 36 months | ||||
Gender | Male | 15 | 100.0 | 78.8 | 0.502 |
Female | 3 | - | - | ||
Age | ≤ 49 years old | 4 | 100.0 | 33.3 | 0.009 |
≥ 50 years old | 14 | - | - | ||
Schooling | Never | 5 | - | - | 0.468 |
Basic incomplete | 11 | 100.0 | 87.5 | ||
Basic complete/ High school | 2 | 100.0 | 50.0 | ||
Tabagism | Never and/or former smoker | 6 | 100.0 | 80.0 | 0.744 |
Current smoker | 9 | 100.0 | 75.0 | ||
Etilism | Never | 6 | - | - | 0.371 |
Ever | 10 | 100.0 | 80.0 | ||
Weight loss | Yes | 7 | - | - | 0.445 |
No | 11 | 100.0 | 77.8 | ||
Odinophagia | Yes | 6 | - | - | 0.335 |
No | 12 | 100.0 | 75.0 | ||
Dysphagia | Yes | 12 | 100.0 | 68.6 | 0.192 |
No | 6 | - | - | ||
Epigastralgia | Yes | 6 | 100.0 | 50.0 | 0.038 |
No | 12 | - | - | ||
Pyrosis | Yes | 4 | - | - | 0.383 |
No | 14 | 100.0 | 76.2 | ||
Body Mass Index (BMI) | ≤ 18.5 | 5 | - | 0.445 | |
>18.5 | 12 | 100.0 | 77.8 | ||
Comorbidity | Absent | 11 | - | - | 0.116 |
Present | 7 | 100.0 | 62.5 | ||
Second primary tumor | Yes | 5 | - | - | 0.383 |
No | 13 | 100.0 | 76.2 | ||
Tumor size | ≤ 2.0 cm | 6 | 100.0 | 80.0 | 0.886 |
> 2.0 cm | 10 | 100.0 | 80.0 | ||
Histological type | Squamous cell carcinoma | 16 | 100.0 | 90.0 | 0.247 |
Adenocarcinoma | 2 | 100.0 | 50.0 | ||
Stage (TNM) | 0 | 3 | - | - | 0.383 |
1 | 15 | 100.0 | 76.2 | ||
Surgery | Yes | 13 | 100.0 | 87.5 | 0.351 |
No | 5 | 100.0 | 66.7 | ||
Radiotherapy | Yes | 6 | 100.0 | 66.7 | 0.351 |
No | 12 | 100.0 | 87.5 | ||
Chemotherapy | Yes | 2 | 100.0 | 0.0 | <0.001 |
No | 16 | - | - | ||
Total | 18 | 100.0 | 82.5 |
Variable | Category | n | Global survival rates probabilities (%) | p (Log-Rank) | |
---|---|---|---|---|---|
12 months | 36 months | ||||
Gender | Male | 15 | 73.3 | 59.3 | 0.302 |
Female | 3 | - | - | ||
Age | ≤ 49 years old | 4 | 100.0 | 66.7 | 0.747 |
≥ 50 years old | 14 | 71.4 | 64.3 | ||
Schooling | Never | 5 | 53.3 | 53.3 | 0.628 |
Basic incomplete | 11 | 81.8 | 72.7 | ||
Basic complete/ High school | 2 | 100.0 | 50.0 | ||
Tabagism | Never and/or former smoker | 6 | 100.0 | 80.0 | 0.188 |
Current smoker | 9 | 50.8 | 50.8 | ||
Etilism | Never | 6 | 83.3 | 66.7 | 0.584 |
Ever | 10 | 67.5 | 54.0 | ||
Weight loss | Yes | 7 | 57.1 | 42.9 | 0.081 |
No | 11 | 90.0 | 80.0 | ||
Odinophagia | Yes | 6 | 83.3 | 66.7 | 0.869 |
No | 12 | 73.3 | 64.2 | ||
Dysphagia | Yes | 12 | 73.3 | 53.5 | 0.294 |
No | 6 | 83.3 | 83.3 | ||
Epigastralgya | Yes | 6 | 80.0 | 60.0 | 0.956 |
No | 12 | 75.0 | 66.7 | ||
Pyrosis | Yes | 4 | - | - | 0.191 |
No | 14 | 71.4 | 56.3 | ||
Body Mass Index (BMI) | ≤ 18.5 | 5 | 60.0 | 60.0 | 0.443 |
>18.5 | 12 | 90.9 | 72.7 | ||
Comorbidity | Absent | 11 | 70.7 | 60.6 | 0.599 |
Present | 7 | 85.7 | 68.6 | ||
Second primary tumor | Yes | 5 | 60.0 | 60.0 | 0.596 |
No | 13 | 83.3 | 65.6 | ||
Tumor size | ≤ 2.0 cm | 6 | 83.3 | 83.3 | 0.315 |
> 2.0 cm | 10 | 78.8 | 54.0 | ||
Histological type | Squamous cell carcinoma | 16 | 73.7 | 67.0 | 0.858 |
Adenocarcinoma | 2 | 100.0 | 50.0 | ||
Stage (TNM) | 0 | 3 | - | - | 0.202 |
1 | 15 | 71.8 | 56.5 | ||
Surgery | Yes | 13 | 75.0 | 65.6 | 0.757 |
No | 5 | 80.0 | 60.0 | ||
Radiotherapy | Yes | 6 | 66.7 | 50.0 | 0.306 |
No | 12 | 81.8 | 71.6 | ||
Chemotherapy | Yes | 2 | 73.7 | 67.0 | 0.858 |
No | 16 | 100.0 | 50.0 | ||
Total | 18 | 76.7 | 64.4 |